Qualcomm has notched a win in its worldwide legal battle with Apple, announcing Friday that a jury in a federal court in San Diego found Apple infringed on three Qualcomm patents and owes the chip giant $31 million in damages.
Devices infringing on at least one of the three non-standard essential patents include the iPhone 7, 7 Plus, 8, 8 Plus and X. One of the three patents cover technology that lets a smartphone quickly connect to the internet once powered on, the second covers tech that acts as Qualcomm calls it a “traffic cop” between the applications processor and the modem, and a third prolongs battery life while enabling high performance and visual graphics for games.
The damages awarded — $1.41 per device—are what Qualcomm requested at the start of the trial and cover infringement of the patents from when Qualcomm first filed the lawsuit on July 6, 2017 through the end of the trial.
The recent win comes as the two tech giants prepare to face off at a high profile trial scheduled for next month. That antitrust case, filed by Apple in 2017, deals with Qualcomm’s patent licensing business model and patent royalties. It is seen by many as what will be the crescendo of the two companies’ legal fight, which involves lawsuits around the world, including Germany and China.
“Today’s unanimous jury verdict is the latest victory in our worldwide patent litigation directed at holding Apple accountable for using our valuable technologies without paying for them,” said Don Rosenberg, executive vice president and general counsel for Qualcomm, in a statement. “The technologies invented by Qualcomm and others are what made it possible for Apple to enter the market and become so successful so quickly. The three patents found to be infringed in this case represent just a small fraction of Qualcomm’s valuable portfolio of tens of thousands of patents. We are gratified that courts all over the world are rejecting Apple’s strategy of refusing to pay for the use of our IP.”
In a statement to Reuters, Apple said “Qualcomm’s ongoing campaign of patent infringement claims is nothing more than an attempt to distract from the larger issues they face with investigations into their business practices in U.S. federal court, and around the world.”